In conclusion, we provide first evidence that miR-21 is expressed in situ in CTCL skin lesions, induced by IL-2 and IL-15 cytokines, and is regulated by STAT5 in malignant T cells. The gene discussed is STAT5B; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.